Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
Date:11/9/2011

ing Group’s updated data set. Time to death specifically attributed to mammary adenocarcinoma was significantly decreased only in the lorcaserin high-dose group. In a second analysis which assumed deaths due to unspecified mammary tumor in rats with both fibroadenoma and adenocarcinoma were caused by adenocarcinoma, time to death was accelerated in the lorcaserin mid-dose group as well, although the incidence of mammary adenocarcinoma was not increased over controls in the mid-dose group.
  • A series of mechanistic studies that are intended to test whether there is a causal relationship between lorcaserin, prolactin and mammary tumor development in rats is ongoing. Arena expects to complete these studies in time to submit the complete response to the FDA around the end of the year.
  • Assigned the UK's Medicines and Healthcare products Regulatory Agency as marketing authorization application Rapporteur and Sweden's Medical Products Agency as Co-rapporteur. Arena also received approval from the Pediatric Development Committee for its pediatric investigation plan application, which defers all pediatric studies until after European Medicines Agency approval.

  • Other recent developments include:

  • Entered into an equity line of credit agreement with Azimuth Opportunity, L.P., or Azimuth, that provides that, upon the terms and subject to the conditions and limitations set forth in the agreement, Azimuth is committed to purchase up to $50 million worth of shares of Arena common stock over a 24-month term. Arena will determine, at its sole discretion, the timing and amount of any sales of its stock, subject to certain conditions.
  • Presented three posters of new data analyses from the lorcaserin Phase 3 clinical trial program at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society.
  • Announced that Robert E. Hoffman rejoined Arena as Vice President, Finance and Chief Financial Officer.

  • Sched
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
    2. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
    3. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
    4. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
    5. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
    6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
    7. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
    8. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
    9. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
    10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
    11. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... , Aug. 27, 2014 TWi ... final approval from the United States Food and ... Application (ANDA) for megestrol acetate 125mg/ml oral suspension, ... TWi is the first-to-file and under Hatch Waxman ... of marketing exclusivity.  TWi has completed the pre-launch ...
    (Date:8/27/2014)... 2014 Reportbuyer.com has added a ... Terms & Agreements in Pharma, Biotech and ... The Co-development Terms and Agreements in ... understanding and unprecedented access to the co-development ... worlds leading life science companies. The ...
    (Date:8/27/2014)... and MENLO PARK, Calif. , ... (OTCQB: DMPI), developer of advanced cancer therapeutics , ... 16th Annual Rodman & Renshaw Global Investment Conference, sponsored ... will take place Tuesday, September 9th at 2:55 p.m. ... the New York Palace Hotel in New ...
    Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 2Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 3Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 4Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 5Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 6Co-development Terms & Agreements in Pharma, Biotech and Diagnostics 7DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4
    (Date:8/28/2014)... 2014 In the healthcare industry, there ... struggle with: How can the overall quality of patient ... of the healthcare industry tackles this question, and has ... job satisfaction and the quality of patient care. ... in “ Organizational Factors related to Improving Quality of ...
    (Date:8/28/2014)... August 28, 2014 Tea Leaves ... with Gigya, the leader in Connected Consumer Management. ... Leaves will have the opportunity to build more ... who they are and how they like to ... the world’s biggest brands to understand and connect ...
    (Date:8/28/2014)... Livermore, CA (PRWEB) August 28, 2014 ... newest California physician, James Patel M.D. of Livermore, California. ... the best and most qualified physicians, and in accordance ... and our patients to Dr. Patel’s practice. , Initially ... at a young age, Dr. Patel was shaped by ...
    (Date:8/28/2014)... 2014 The need for larger space has ... few years. The new location - 4700 Bryant Irvin Court, ... larger office space than TLC had in the past, as ... pleased about our new location because it represents a good ... be double in size compared to the current one, the ...
    (Date:8/27/2014)... August 28, 2014 Author and orthopedic ... takes readers on the thrilling adventures of sharp and ... in 2012, is gearing up for a new marketing ... into two novellas , “Prescription: Murder” follows the ... finds himself dodging assassination attempts and thwarting criminals. In ...
    Breaking Medicine News(10 mins):Health News:New Healthcare Study Explores Strategies for Improving Patient Care 2Health News:New Healthcare Study Explores Strategies for Improving Patient Care 3Health News:New Healthcare Study Explores Strategies for Improving Patient Care 4Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:William H. Simon Launches New Marketing Campaign for Book 2
    ... the US, WAYNE, N.J., May 20 Maureen McCormick, ... sitcom, The Brady Bunch, is the new,celebrity ambassador for the ... by storm and is now available in the,United States., ... lost over 30,lbs. and was announced winner of the fifth ...
    ... certification ... Enterprise software, PARSIPPANY, N.J., May 20 Satyam Computer,Services ... information,technology services provider, and GE Healthcare, today announced a,comprehensive agreement ... Enterprise software., The companies will join forces to plan, ...
    ... in Nature Nanotechnology suggests some forms of carbon nanotubes ... be as harmful as asbestos if inhaled in sufficient quantities. ... types of nanotubes have the potential to cause mesothelioma ... years to appear following exposure. The results show that ...
    ... Intensive therapy did not improve recovery or survival, researchers ... Intensive kidney dialysis for patients with acute kidney injury ... the rate of organ failure, a new study finds. ... in critically ill patients. Approximately 2 percent to 7 ...
    ... Improving, Animal Health and Well-Being; Co-sponsored by Hill,s Pet ... FANCY, CAT FANCY and Veterinary Practice News Magazines, ... veterinarian is the,best in America, nominate him or her ... Pet(SM) Contest. The national short-essay contest honors,America,s veterinarians for ...
    ... TSP-1 expression has been found to correlate with the ... rat livers with high vascular densityin other words, angiogenesis. ... Glsm zlem Elpek, is described in a research article ... World Journal of Gastroenterology. , Thrombospondin 1 (TSP-1) is ...
    Cached Medicine News:Health News:TV Icon Takes a Shot at Staying Slim 2Health News:GE and Satyam Announce Global Alliance to Provide Healthcare IT Services 2Health News:GE and Satyam Announce Global Alliance to Provide Healthcare IT Services 3Health News:GE and Satyam Announce Global Alliance to Provide Healthcare IT Services 4Health News:Carbon nanotubes that look like asbestos, behave like asbestos 2Health News:Carbon nanotubes that look like asbestos, behave like asbestos 3Health News:More Dialysis Not Better in Acute Kidney Injury 2Health News:Morris Animal Foundation Searches for America's Best Vet With 'Thank Your Vet for a Healthy Pet(SM)' Contest 2Health News:Morris Animal Foundation Searches for America's Best Vet With 'Thank Your Vet for a Healthy Pet(SM)' Contest 3
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: